EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -46.9% | 14,841 | +17.0% | 0.00% | 0.0% |
| Q4 2021 | $32,000 | -51.5% | 12,682 | -1.4% | 0.00% | -50.0% |
| Q3 2021 | $66,000 | +312.5% | 12,865 | +576.4% | 0.00% | +100.0% |
| Q2 2021 | $16,000 | -44.8% | 1,902 | -41.9% | 0.00% | 0.0% |
| Q1 2021 | $29,000 | -53.2% | 3,273 | -42.5% | 0.00% | -66.7% |
| Q4 2020 | $62,000 | +463.6% | 5,695 | +530.0% | 0.00% | +200.0% |
| Q3 2020 | $11,000 | -93.3% | 904 | -91.1% | 0.00% | -94.4% |
| Q2 2020 | $163,000 | +1937.5% | 10,179 | +1838.9% | 0.02% | +350.0% |
| Q1 2020 | $8,000 | +100.0% | 525 | +67.2% | 0.00% | +100.0% |
| Q1 2019 | $4,000 | – | 314 | +946.7% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 30 | -98.4% | 0.00% | -100.0% |
| Q1 2018 | $34,000 | +3300.0% | 1,899 | +4120.0% | 0.02% | +1700.0% |
| Q4 2017 | $1,000 | -75.0% | 45 | -79.0% | 0.00% | -66.7% |
| Q3 2017 | $4,000 | – | 214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |